
    
      Eligible women 13-21 weeks gestation who give informed consent will be randomized to receive
      buccal or sublingual misoprostol. Participants will take 200mg mifepristone and return to the
      hospital 24 hours later to begin induction with misoprostol. 400mcg misoprostol will be given
      every 3 hours until the expulsion of the fetus and placenta.
    
  